ClinConnect ClinConnect Logo
Search / Trial NCT01759225

Registry of Cardiovascular Disease Patients

Launched by MACCABI HEALTHCARE SERVICES, ISRAEL · Dec 27, 2012

Trial Information

Current as of June 26, 2025

Enrolling by invitation

Keywords

Registry, Cardiovascular, Cvd, Health Maintenance Organization

ClinConnect Summary

The registry was initiated in 1998 by Maccabi Healthcare services, which is the second largest publicly funded HMO in Israel,serving 24% of the total population with a nationwide distribution.

The registry uses advanced information technology that integrates personal computerized community and hospital records, data from laboratory tests, dispensed medications, physiological signals, radiological images, and reports from investigations and procedures.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * Clinical Diagnosis of the following:
  • Ischemic Heart Disease,MI,non-MI,congestive heart failure,peripheral vascular disease, cerebrovascular disease CVA,TIA,patients with first AMI diagnosis from community physicians if they were hospitalized for lasting at least 3 days during a 30-day period prior to diagnosis.
  • Patients with prior coronary artery bypass grafting(CABG) or percutaneous coronary intervention (PCI), using relevant Current Procedural Terminology (CPT) codes
  • Exclusion Criteria:
  • patients who were diagnosed as suffering from CHD by primary physician or general hospitals prior to 2000 with no further indication
  • Patients whose primary physician reported that the patient is CHD-free providing adequate medical records

About Maccabi Healthcare Services, Israel

Maccabi Healthcare Services, one of Israel's leading health maintenance organizations, is dedicated to advancing healthcare through innovative clinical research and trials. With a robust network of healthcare professionals and state-of-the-art facilities, Maccabi fosters a patient-centered approach, ensuring high-quality care and ethical standards in all research activities. The organization is committed to enhancing treatment options and improving patient outcomes by actively contributing to medical knowledge and evidence-based practices in various therapeutic areas. Through collaboration with academic institutions and industry partners, Maccabi aims to drive the future of healthcare in Israel and beyond.

Locations

Tel Aviv, , Israel

Patients applied

0 patients applied

Trial Officials

Gabriel Chodick, PHD

Study Director

Head,Epidemiology & Database Reseaech Unit, Medical Division, Maccabi H.S

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials